Celltrion Healthcare Revenue and Competitors

Incheon,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Celltrion Healthcare's estimated annual revenue is currently $97.7M per year.(i)
  • Celltrion Healthcare's estimated revenue per employee is $201,000

Employee Data

  • Celltrion Healthcare has 486 Employees.(i)
  • Celltrion Healthcare grew their employee count by 33% last year.

Celltrion Healthcare's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Celltrion Healthcare?

Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 120 different countries. Celltrion Healthcare provides REMSIMA, the world's first biosimilar monoclonal antibody (mAb) approved by the European Medicines Agency (EMA) for the treatment of autoimmune disease, and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world.

keywords:N/A

N/A

Total Funding

486

Number of Employees

$97.7M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Celltrion Healthcare News

2022-04-20 - K-bio names with stocks in downward spiral rush to appease ...

Earlier this year, Celltrion, Celltrion Healthcare, Hanall Biopharma, Huons Global, Humasis, Medytox, and HK inno.

2022-04-06 - Celltrion Healthcare announces the availability of Yuflyma®, a ...

Celltrion Healthcare announces the availability of Yuflyma®, a high-concentration, low-volume, citrate-free, and latex-free Humira® (adalimumab)...

2022-03-30 - Celltrion Announces Agreement with Brazilian Government to ...

On March 24, 2022, Celltrion Healthcare announced that it had won a bid to the Brazilian Federal Government to supply a biosimilar version...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$189.4M12220%N/A